Skip to content

AptarGroup ATR Pharma — Total Assets

Other segment segments

Beauty
$1.69B
Closures
$799.4M

Similar metrics at other companies

International Flavors & Fragrances logo
IFFPharma Solutions — Total Assets
$3.15B-2.5%
Abbott logo
ABTEstablished Pharmaceuticals — Total Assets
$3.67B+6.3%
Cardinal Health logo
CAHPharmaceutical and Specialty Solutions — Total Assets
$41.03B+14.8%
Agilent Technologies logo
ALife Sciences and Applied Markets — Total Assets
$3.14B-0.7%
Revvity logo
RVTYAssets Total — Total Assets
$6.09B+42.4%
Thermo Fisher Scientific logo
TMOLaboratory Products and Biopharma Services — Segment assets
$6.92B+7.0%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: AptarGroup’s 10-K, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's pharma — total assets?
AptarGroup (ATR) reported pharma — total assets of $2.28B in Q4 2025.
What does pharma — total assets mean?
The total value of all assets owned and utilized by the Pharma business segment.
How do you interpret pharma — total assets?
An increase suggests capital expansion or investment in production capacity, while a decrease may indicate asset divestiture or depreciation.
How does pharma — total assets compare across companies?
Standard segment-level asset disclosure required for segment reporting under GAAP/IFRS.